Transplant Diagnostics Market Size, Share, Growth, Trends and Product Analysis Report
by Susan Hill Business ConsultantThe
global transplant diagnostics market size is expected to
reach USD 895.2 million by 2024, according to a new report by Grand View
Research, Inc. It is projected to expand at a CAGR of 7.6% over the forecast
period. Increasing number of patients suffering from chronic diseases
frequently leading to organ failure is creating an upsurge in demand for
transplant procedures. In addition, adoption of stem cell therapy and
personalized medicine is escalating, thereby influencing demand for transplant
diagnostics.
Risks and
complexities associated with organ transplants necessitate the need for
improved and sophisticated diagnostic tools. Next-Generation
Sequencing (NGS) technology is rapidly replacing traditional diagnostic
methods, such as serological techniques employed in Human Leukocyte Antigen
(HLA) typing, owing to growing demand for high-throughput diagnostic tools with
enhanced accuracy.
Market
growth is expected to be restrained by factors such as reimbursement
controversies and ethical issues in some parts of the world. In addition, high
cost of performing HLA matching using Polymerase Chain Reaction (PCR) and NGS
devices is challenging the growth of the transplant diagnostics market in
developing countries.
Further key
findings from the study suggest:
- PCR-based
molecular assay captured the largest share in the overall market in 2016
due to extensive adoption in HLA typing
- The
sequencing-based typing segment is anticipated to witness significant
growth from 2016 to 2024. High adoption of NGS is a major factor driving
segment growth
- In 2016, the
reagents and consumables segment accounted for the largest market share
attributed to repeat purchase
- North America
captured the largest revenue share in 2016 and is expected to maintain its
dominance throughout the forecast period due to well-established research
infrastructure, increasing healthcare expenditure, high adoption of advanced
diagnostic techniques, and growing R&D activities
- Asia Pacific is
expected to witness significant growth during the forecast period owing to
expanding research opportunities, healthcare expenditure, medical
tourism industry, and awareness regarding organ donation
- Some major
players in this market are Thermo Fisher Scientific, Inc.; Illumina, Inc.;
F.Hoffmann La-Roche AG.; Abbott Laboratories, Inc.; Qiagen N.V.; Immucor
Transplant Diagnostics, Inc.; Bio-Rad Laboratories, Inc.; Affymetrix,
Inc.; and Omixon Ltd.
Access full
research report on global transplant diagnostics market:
www.grandviewresearch.com/industry-analysis/transplant-diagnostic-market
Sponsor Ads
Created on Sep 18th 2019 09:12. Viewed 378 times.